Harvard Medical Science Researcher Wins NIH Director’s Transformative Research Award

This award supports individuals and their teams who propose unconventional, out-of-the-box and exceptionally innovative research projects.

Study in US: Blavatnik Institute at Harvard Medical School's Ryan Flynn, assistant professor of stem cell and regenerative biology has received a National Institutes of Health (NIH) Director’s Transformative Research Award.

This is given for proposals which are not only unconventional, and exceptionally innovative but are untested and inherently risky and have the potential to challenge or create fundamental paradigms.

This year, a total of 67 researchers have received the High-Risk, High-Reward Research program award which is valued at approximately $207 million.

Tara Schwetz, Director of the NIH Division of Program Coordination, Planning, and Strategic Initiatives said, “The HRHR program champions exceptionally bold and innovative science that pushes the boundaries of biomedical and behavioral research. The groundbreaking science pursued by these researchers is poised to have a broad impact on human health."

Ryan Flynn Research Details

He is trying to understand how cells communicate using RNA-binding proteins and cell surface RNA which could help in understanding how cancer exploits this communication. His lab studies the glycoRNA molecule. It operates at the interface of RNA cell surface, glycobiology, and biology in the context of human disease.

Along with common funding, the award is funded jointly by NIH’s National Library of Medicine; National Institute of General Medical Sciences; National Institute of Mental Health; National Heart, Lung, and Blood Institute; National Institute on Aging; and Office of Dietary Supplements.

Harvard Medical Science Awards & Recognitions In October 2024

Gary Ruvkun, professor of genetics at Harvard Medical School and an investigator at Massachusetts General Hospital has shared the 2024 Nobel Prize in Physiology or Medicine with collaborator Victor Ambros of the University of Massachusetts Chan Medical School. The 2024 William B. Coley Award for Distinguished Research in Basic and Tumor Immunology award was received by two HMS researchers, Christophe Benoist and Diane Mathis were honored at the CRI’s 2024 Awards Gala. They are both Morton Grove-Rasmussen Professors of Immunohematology at the Blavatnik Institute at Harvard Medical School. Seven researchers named 2024 STAT Wunderkinds. They are HMS early-career researchers.

Read more:

• Study Abroad: Apply For Faculty Scholarships At Delft University Of Technology Netherlands
• Study in UK: University of Exeter Inks New Sustainability Concordat